Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2018 Mar 22;9:76. doi: 10.1186/s13287-018-0845-x

Correction to: Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro

Bo Liu 1,3, Fengxia Ding 2,3, Dong Hu 3, Yu Zhou 3, Chunlan Long 3, Lianju Shen 3, Yuanyuan Zhang 4, Deying Zhang 1,3,, Guanghui Wei 1
PMCID: PMC5865288  PMID: 29566747

Erratum

The original article [1] contains an error whereby the corresponding authorship is mistakenly designated to the author Fengxia Ding.

The authors would like to clarify that Deying Zhang is the actual corresponding author for this manuscript, and all queries concerning the manuscript should be addressed to deyingzhang@126.com instead.

Footnotes

The original article can be found online at https://doi.org/10.1186/s13287-017-0760-6.

Reference

  • 1.Liu B, et al. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro. Stem Cell Res Ther. 2018;9:7. doi: 10.1186/s13287-017-0760-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES